HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. lessened its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 47.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 57,384 shares of the company’s stock after selling 51,778 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned 0.07% of HealthEquity worth $5,506,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the business. Arcadia Investment Management Corp MI bought a new position in HealthEquity during the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC lifted its holdings in HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after buying an additional 98 shares during the last quarter. UMB Bank n.a. lifted its holdings in HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the last quarter. Lindbrook Capital LLC lifted its holdings in HealthEquity by 27.6% during the 4th quarter. Lindbrook Capital LLC now owns 750 shares of the company’s stock worth $72,000 after buying an additional 162 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its holdings in HealthEquity by 50.7% during the 4th quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company’s stock worth $107,000 after buying an additional 375 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Buying and Selling at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.20% of the stock is owned by company insiders.

Analysts Set New Price Targets

HQY has been the topic of a number of research analyst reports. JMP Securities increased their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Raymond James increased their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Tuesday, February 25th. Mizuho started coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Wells Fargo & Company raised their price target on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Finally, Royal Bank of Canada raised their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $112.92.

HealthEquity Stock Up 3.7 %

Shares of HealthEquity stock opened at $97.41 on Monday. The business’s fifty day moving average price is $105.68 and its two-hundred day moving average price is $95.35. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a market capitalization of $8.44 billion, a P/E ratio of 89.37, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.